Liver cancer impact in Mississippi among largest in US
“JACKSON, Miss. (WJTV) – Recent data suggests that Mississippians are dying from liver cancer at alarming rates. According to research cited by the American Association for Cancer Research, the incidence of liver cancer increased by 75% worldwide between 1990 and 2015. It is also on the rise in Mississippi. Mississippi’s mortality rate from Liver Cancer was the 7th highest in the country from 2012-2016. According to the Centers for Disease Control and Prevention (CDC), Mississippi’s death rate increased to the 4th highest between 2015 to 2019. Death from liver cancer among white males in Mississippi is the second highest nationally.”
Why L.A.’s battle against a deadly disease relies on unpaid volunteers
“As evening fell in her Glendale apartment, Dara Bruce fed her pet rats George and Fred, poured herself a glass of water, and dialed a complete stranger to discuss the dangerous virus detected in his blood.”
Machine-Learning Revolutionizes Hepatitis C Virus Screening: A Leap Towards Efficiency
“Technological advancements in the healthcare sector continue to offer innovative solutions for disease detection and management. One such development is the use of machine learning (ML) algorithms in disease screening, which has shown significant potential in improving efficiency. A prime example of this is the recent nationwide implementation of a machine-learning–based Hepatitis C (Hep-C) screening technique.”
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019
“This study aimed to assess the global, regional, and national burden of liver cirrhosis and other chronic liver diseases between 1990 and 2019, considering five etiologies (hepatitis B, hepatitis C, alcohol use, NAFLD and other causes), age, gender, and sociodemographic index (SDI).”
The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL)
“The number of cancer cases diagnosed during the coronavirus disease 2019 (COVID-19) pandemic has decreased. This study investigated the impact of the pandemic on the clinical practice of hepatocellular carcinoma (HCC) using a novel nationwide REgistry for Advanced Liver diseases (REAL) in Japan.”
Hep C’s number comes up
“Rick Jaenisch went through treatment six times before his hepatitis C was cured in 2017. Each time his doctors recommended a different combination of drugs, his insurer denied the initial request before eventually approving it. This sometimes delayed his care for months, even after he developed end-stage liver disease and was awaiting a liver transplant.”
Assessing and Improving the Health-Related Quality of Life Among People Who Inject Drugs
“Drug use is a topic we’ve increasingly worked to address, ranging from providing needle exchange programs, harm reduction strategies, mental health services, and seeking to address marginalization and access to care. Following a pandemic that amplified many stressors, there is a renewed interest in trying to better support people who inject drugs (PWID) and struggle with addiction.”
